Patents by Inventor Amir Mor

Amir Mor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND COMPOSITIONS FOR THE TREATMENT OF INFLUENZA
    Publication number: 20220073495
    Abstract: The present disclosure provides, in part, compositions, kits and methods for treating or preventing an influenza viral infection by administering a therapeutically effective amount of an inhibitor of influenza viral M mRNA nuclear export to a subject in need.
    Type: Application
    Filed: November 16, 2021
    Publication date: March 10, 2022
    Applicant: The Board of Regents of The Universtiy of Texas System
    Inventors: Beatriz M.A. Fontoura, Matthew A. Esparza, Hanspeter Niederstrasser, Bruce Posner, Joseph M. Ready, Amir Mor
  • Methods for identification of pregnancy failure
    Patent number: 11105816
    Abstract: Provided is a method for identifying and treating a pregnancy devoid of uterine fetal or embryonic tissue in a subject by determining a concentration of alpha-fetoprotein (AFP) in a specimen evacuated from the uterus of the subject; comparing the concentration of AFP to a reference value; wherein when the AFP concentration in the specimen evacuated from the uterus is below that of a reference value, absence of uterine fetal or embryonic tissue is indicated. Also provided is a method for identifying and treating a presence of fetal or embryonic tissue in a location of a subject other than the uterus by determining a concentration of AFP in a non-uterine specimen obtained from the subject; comparing the concentration of AFP in the specimen to a reference value; wherein when the AFP concentration in the specimen is above that of a reference value, presence of fetal or embryonic tissue is indicated.
    Type: Grant
    Filed: November 13, 2019
    Date of Patent: August 31, 2021
    Inventor: Amir Mor
  • METHODS FOR IDENTIFICATION OF PREGNANCY FAILURE
    Publication number: 20200096517
    Abstract: Provided is a method for identifying and treating a pregnancy devoid of uterine fetal or embryonic tissue in a subject by determining a concentration of alpha-fetoprotein (AFP) in a specimen evacuated from the uterus of the subject; comparing the concentration of AFP to a reference value; wherein when the AFP concentration in the specimen evacuated from the uterus is below that of a reference value, absence of uterine fetal or embryonic tissue is indicated. Also provided is a method for identifying and treating a presence of fetal or embryonic tissue in a location of a subject other than the uterus by determining a concentration of AFP in a non-uterine specimen obtained from the subject; comparing the concentration of AFP in the specimen to a reference value; wherein when the AFP concentration in the specimen is above that of a reference value, presence of fetal or embryonic tissue is indicated.
    Type: Application
    Filed: November 13, 2019
    Publication date: March 26, 2020
    Inventor: Amir Mor
  • Methods for identification of pregnancy failure
    Patent number: 10509043
    Abstract: Provided is a method for identifying pregnancy failure in a subject, the method comprising determining a concentration of at least one element of fetal or embryonic origin in the vaginal fluid of the subject; and comparing the concentration of the at least one element of fetal or embryonic origin to a reference value, wherein when the concentration of the at least one element of fetal or embryonic origin in the vaginal fluid is higher than the reference value, pregnancy failure is indicated.
    Type: Grant
    Filed: April 12, 2018
    Date of Patent: December 17, 2019
    Inventor: Amir Mor
  • METHODS FOR IDENTIFICATION OF PREGNANCY FAILURE
    Publication number: 20180299459
    Abstract: Provided is a method for identifying pregnancy failure in a subject, the method comprising determining a concentration of at least one element of fetal or embryonic origin in the vaginal fluid of the subject; and comparing the concentration of the at least one element of fetal or embryonic origin to a reference value, wherein when the concentration of the at least one element of fetal or embryonic origin in the vaginal fluid is higher than the reference value, pregnancy failure is indicated.
    Type: Application
    Filed: April 12, 2018
    Publication date: October 18, 2018
    Inventor: Amir Mor